DuoNeb and ipratropium are somewhat the same as DuoNeb is a combination of ipratropium bromide and albuterol sulfate.
DuoNeb contains albuterol suflate and ipratropium.
The second name for ipratropium is Atrovent which is the brand name for ipratropium.
Ipratropium also known as Atrovent is a bronchodilator medication that dilates the airways of the lungs.
The medication ipratropium has been approved by the US Food and Drug Administration (FDA) for treating bronchospasms associated with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.
Ipratropium is used to help control the symptoms of lung diseases, such as asthma, chronic bronchitis, and emphysema.
Ipratropium is also used to treat air flow blockage and prevent the worsening of chronic obstructive pulmonary disease (COPD).
Ipratropium belongs to the family of medicines known as bronchodilators.
In people with chronic obstructive airway disease, ipratropium produces a longer duration of action than albuterol.
It is more effective than albuterol in treating severely obstructed individuals and those not responding to metaproterenol.
Ipratropium acts as an antagonist of the muscarinic acetylcholine receptor.
This effect produces the inhibition of the parasympathetic nervous system in the airways and hence, inhibit their function.
Ipratropium and albuterol combination is used to help control the symptoms of lung diseases, such as asthma, chronic bronchitis, and emphysema.
It is also used to treat air flow blockage and prevent the worsening of chronic obstructive pulmonary disease (COPD) in patients who need another medicine.
Ipratropium/albuterol may increase your risk of certain heart problems, such as raising your heart rate, blood pressure, or causing an abnormal heart rhythm (arrhythmia).
Ipratropium when taken at bedtime can improve the quality of sleep.
It can also improve nighttime arterial oxygen saturation levels.
The latter may assist in reducing the incidence and severity of pulmonary hypertension.